Global Cardiac Safety Services Market to Reach $1.6 Billion by 2030
The global market for Cardiac Safety Services estimated at US$734.1 Million in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2022-2030. ECG / Holter Measurement, one of the segments analyzed in the report, is projected to record 9.9% CAGR and reach US$475.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Blood Pressure Measurement segment is readjusted to a revised 11.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $200 Million, While China is Forecast to Grow at 14.4% CAGR
The Cardiac Safety Services market in the U.S. is estimated at US$200 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$361.8 Million by the year 2030 trailing a CAGR of 14.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 7.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.Select Competitors (Total 34 Featured) -
- Banook Group
- Bioclinica (A Subsidiary of Cinven)
- BioTelemetry, Inc.
- Biotrial
- Celerion, Inc.
- Certara, L.P.
- ERT, Inc.
- IQVIA
- Labcorp
- Medpace
- Ncardia
- Pharmaceutical Product Development LLC
- PhysioStim
- Richmond Pharmacology
- SGS S.A.
- Shanghai Medicilon Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Banook Group
- Bioclinica (A Subsidiary of Cinven)
- BioTelemetry, Inc.
- Biotrial
- Celerion, Inc.
- Certara, L.P.
- ERT, Inc.
- IQVIA
- Labcorp
- Medpace
- Ncardia
- Pharmaceutical Product Development LLC
- PhysioStim
- Richmond Pharmacology
- SGS S.A.
- Shanghai Medicilon Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 734.1 Million |
Forecasted Market Value ( USD | $ 1600 Million |
Compound Annual Growth Rate | 10.2% |
Regions Covered | Global |